Targeting mutant p53 by a SIRT1 activator YK-3-237 inhibits the proliferation of triple-negative breast cancer cells. [electronic resource]
Producer: 20140522Description: 984-94 p. digitalISSN:- 1949-2553
- Acetylation -- drug effects
- Apoptosis -- physiology
- Boronic Acids -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Chalcones -- pharmacology
- Female
- Gene Expression -- drug effects
- Humans
- Molecular Targeted Therapy
- RNA, Small Interfering -- genetics
- Sirtuin 1 -- genetics
- Transfection
- Triple Negative Breast Neoplasms -- drug therapy
- Tumor Suppressor Protein p53 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.